{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:10:58Z","timestamp":1789398658750,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12020-022-03008-9","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T19:02:20Z","timestamp":1644606140000},"page":"612-619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prolonged survival of anaplastic thyroid carcinoma is associated with resectability, low tumor-infiltrating neutrophils\/myeloid-derived suppressor cells, and low peripheral neutrophil-to-lymphocyte ratio"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4638-9835","authenticated-orcid":false,"given":"Bin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Setoodeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinita S.","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Landa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Balzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Tiedje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ganly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snjezana","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Fagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Ghossein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"3008_CR1","first-page":"5888","volume":"11","author":"B Lin","year":"2019","unstructured":"B. Lin, H. Ma, M. Ma, Z. Zhang, Z. Sun et al. The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis. Am J. Transl. Res. 11, 5888\u20135896 (2019)","journal-title":"Am J. Transl. Res."},{"key":"3008_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.wjorl.2018.05.006","volume":"5","author":"TA Janz","year":"2019","unstructured":"T.A. Janz, D.M. Neskey, S.A. Nguyen, E.J. Lentsch, Is the incidence of anaplastic thyroid cancer increasing: a population based epidemiology study. World J. Otorhinolaryngol. Head. Neck Surg. 5, 34\u201340 (2019)","journal-title":"World J. Otorhinolaryngol. Head. Neck Surg."},{"key":"3008_CR3","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1210\/jc.2017-01180","volume":"102","author":"N Prasongsook","year":"2017","unstructured":"N. Prasongsook, A. Kumar, A.V. Chintakuntlawar, R.L. Foote, J. Kasperbauer et al. Survival in response to multimodal therapy in anaplastic thyroid cancer. J. Clin. Endocrinol. Metab. 102, 4506\u20134514 (2017)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3008_CR4","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1089\/thy.2020.0086","volume":"30","author":"B Xu","year":"2020","unstructured":"B. Xu, T. Fuchs, S. Dogan, I. Landa, N. Katabi et al. Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases. Thyroid 30, 1505\u20131517 (2020)","journal-title":"Thyroid"},{"key":"3008_CR5","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1245\/s10434-014-3545-5","volume":"21","author":"A Mohebati","year":"2014","unstructured":"A. Mohebati, M. Dilorenzo, F. Palmer, S.G. Patel, D. Pfister et al. Anaplastic thyroid carcinoma: a 25-year single-institution experience. Ann. Surg. Oncol. 21, 1665\u20131670 (2014)","journal-title":"Ann. Surg. Oncol."},{"key":"3008_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canep.2018.01.011","volume":"53","author":"GB Hvilsom","year":"2018","unstructured":"G.B. Hvilsom, S.C. Londero, C.H. Hahn, S. Schytte, H.B. Pedersen et al. Anaplastic thyroid carcinoma in Denmark 1996-2012: a national prospective study of 219 patients. Cancer Epidemiol. 53, 65\u201371 (2018)","journal-title":"Cancer Epidemiol."},{"key":"3008_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1530\/EJE-16-0574","volume":"175","author":"J Wendler","year":"2016","unstructured":"J. Wendler, M. Kroiss, K. Gast, M.C. Kreissl, S. Allelein et al. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany. Eur. J. Endocrinol.\/Eur. Federation Endocr. Soc. 175, 521\u2013529 (2016)","journal-title":"Eur. J. Endocrinol.\/Eur. Federation Endocr. Soc."},{"key":"3008_CR8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00268-012-1437-z","volume":"36","author":"I Sugitani","year":"2012","unstructured":"I. Sugitani, A. Miyauchi, K. Sugino, T. Okamoto, A. Yoshida et al. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J. Surg. 36, 1247\u20131254 (2012)","journal-title":"World J. Surg."},{"key":"3008_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ccell.2021.01.009","volume":"39","author":"K Kos","year":"2021","unstructured":"K. Kos, K.E. de Visser, Neutrophils create a fertile soil for metastasis. Cancer Cell 39, 301\u2013303 (2021)","journal-title":"Cancer Cell"},{"key":"3008_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10555-020-09947-x","volume":"40","author":"K Cole","year":"2021","unstructured":"K. Cole, K. Pravoverov, J.E. Talmadge, Role of myeloid-derived suppressor cells in metastasis. Cancer Metastasis Rev. 40, 391\u2013411 (2021)","journal-title":"Cancer Metastasis Rev."},{"key":"3008_CR11","doi-asserted-by":"publisher","first-page":"565165","DOI":"10.3389\/fimmu.2020.565165","volume":"11","author":"M Wu","year":"2020","unstructured":"M. Wu, M. Ma, Z. Tan, H. Zheng, X. Liu, Neutrophil: a new player in metastatic cancers. Front. Immunol. 11, 565165 (2020)","journal-title":"Front. Immunol."},{"key":"3008_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fonc.2020.00165","volume":"10","author":"R Trovato","year":"2020","unstructured":"R. Trovato, S. Cane, V. Petrova, S. Sartoris, S. Ugel et al. The engagement between MDSCs and metastases: partners in crime. Front. Oncol. 10, 165 (2020)","journal-title":"Front. Oncol."},{"key":"3008_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/cells9030561","volume":"9","author":"AMK Law","year":"2020","unstructured":"A.M.K. Law, F. Valdes-Mora, D. Gallego-Ortega, Myeloid-derived suppressor cells as a therapeutic target for cancer. Cells 9, 561 (2020).","journal-title":"Cells"},{"key":"3008_CR14","doi-asserted-by":"publisher","first-page":"e98259","DOI":"10.1371\/journal.pone.0098259","volume":"9","author":"M Shen","year":"2014","unstructured":"M. Shen, P. Hu, F. Donskov, G. Wang, Q. Liu et al. Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PloS One 9, e98259 (2014)","journal-title":"PloS One"},{"key":"3008_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20935-9","volume":"12","author":"C Valero","year":"2021","unstructured":"C. Valero, M. Lee, D. Hoen, K. Weiss, D.W. Kelly et al. Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors. Nat. Commun. 12, 729 (2021)","journal-title":"Nat. Commun."},{"key":"3008_CR16","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1089\/thy.2000.10.1113","volume":"10","author":"T Sato","year":"2000","unstructured":"T. Sato, M. Omura, J. Saito, A. Hirasawa, Y. Kakuta et al. Neutrophilia associated with anaplastic carcinoma of the thyroid: production of macrophage colony-stimulating factor (M-CSF) and interleukin-6. Thyroid 10, 1113\u20131118 (2000)","journal-title":"Thyroid"},{"key":"3008_CR17","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3390\/cancers13081913","volume":"13","author":"J Park","year":"2021","unstructured":"J. Park, J. Park, J.H. Shin, Y.L. Oh, H.A. Jung, et al. Prognostic value of the neutrophil-to-lymphocyte ratio before and after radiotherapy for anaplastic thyroid carcinoma. Cancers 13 13, 1913 (2021).","journal-title":"Cancers 13"},{"key":"3008_CR18","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.21873\/invivo.12113","volume":"34","author":"N Fukuda","year":"2020","unstructured":"N. Fukuda, K. Toda, Y.U. Fujiwara, X. Wang, A. Ohmoto et al. Neutrophil-to-lymphocyte ratio as a prognostic marker for anaplastic thyroid cancer treated with lenvatinib. In vivo 34, 2859\u20132864 (2020)","journal-title":"In vivo"},{"key":"3008_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"D.T. Cheng, T.N. Mitchell, A. Zehir, R.H. Shah, R. Benayed et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J. Mol. Diagn. 17, 251\u2013264 (2015)","journal-title":"J. Mol. Diagn."},{"key":"3008_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"A.J. Gentles, A.M. Newman, C.L. Liu, S.V. Bratman, W. Feng et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat. Med. 21, 938\u2013945 (2015)","journal-title":"Nat. Med."},{"key":"3008_CR21","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1677\/ERC-08-0036","volume":"15","author":"M Ryder","year":"2008","unstructured":"M. Ryder, R.A. Ghossein, J.C. Ricarte-Filho, J.A. Knauf, J.A. Fagin, Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr.-Relat. Cancer 15, 1069\u20131074 (2008)","journal-title":"Endocr.-Relat. Cancer"},{"key":"3008_CR22","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"I. Landa, T. Ibrahimpasic, L. Boucai, R. Sinha, J.A. Knauf et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Investig. 126, 1052\u20131066 (2016)","journal-title":"J. Clin. Investig."},{"key":"3008_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4158\/EP-2018-0342","volume":"25","author":"GQ Zhang","year":"2019","unstructured":"G.Q. Zhang, W.J. Wei, H.J. Song, Z.K. Sun, C.T. Shen et al. Programmed cell death-ligand 1 overexpression in thyroid cancer. Endocr. Pract. 25, 279\u2013286 (2019)","journal-title":"Endocr. Pract."},{"key":"3008_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3892\/ol.2021.12814","volume":"22","author":"S Cameselle-Garcia","year":"2021","unstructured":"S. Cameselle-Garcia, S. Abdulkader-Sande, M. Sanchez-Ares, G. Rodriguez-Carnero, J. Garcia-Gomez et al. PD-L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: a retrospective study. Oncol. Lett. 22, 553 (2021)","journal-title":"Oncol. Lett."},{"key":"3008_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12022-020-09630-5","volume":"31","author":"I Girolami","year":"2020","unstructured":"I. Girolami, L. Pantanowitz, O. Mete, M. Brunelli, S. Marletta et al. Programmed death-ligand 1 (PD-L1) is a potential biomarker of disease-free survival in papillary thyroid carcinoma: a systematic review and meta-analysis of PD-L1 immunoexpression in follicular epithelial derived thyroid carcinoma. Endocr. Pathol. 31, 291\u2013300 (2020)","journal-title":"Endocr. Pathol."},{"key":"3008_CR26","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1200\/JCO.19.02727","volume":"38","author":"J Capdevila","year":"2020","unstructured":"J. Capdevila, L.J. Wirth, T. Ernst, S. Ponce Aix, C.C. Lin et al. PD-1 blockade in anaplastic thyroid carcinoma. J. Clin. Oncol. 38, 2620\u20132627 (2020)","journal-title":"J. Clin. Oncol."},{"key":"3008_CR27","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/cancers11070984","volume":"11","author":"G Al-Khadairi","year":"2019","unstructured":"G. Al-Khadairi, J. Decock, Cancer testis antigens and immunotherapy: where do we stand in the targeting of PRAME? Cancers 11, 984 (2019).","journal-title":"Cancers"},{"key":"3008_CR28","first-page":"8828579","volume":"2020","author":"J Li","year":"2020","unstructured":"J. Li, J. Yin, J. Zhong, Z. Yang, A. Tang et al. Clinicopathological and prognostic significance of PRAME overexpression in human cancer: a meta-analysis. BioMed. Res. Int. 2020, 8828579 (2020)","journal-title":"BioMed. Res. Int."},{"key":"3008_CR29","doi-asserted-by":"publisher","first-page":"636568","DOI":"10.3389\/fimmu.2021.636568","volume":"12","author":"K Dhatchinamoorthy","year":"2021","unstructured":"K. Dhatchinamoorthy, J.D. Colbert, K.L. Rock, Cancer immune evasion through loss of MHC class I antigen presentation. Front. Immunol. 12, 636568 (2021)","journal-title":"Front. Immunol."},{"issue":"Suppl 1","key":"3008_CR30","doi-asserted-by":"publisher","first-page":"E2083","DOI":"10.1002\/hed.24384","volume":"38","author":"SM Glaser","year":"2016","unstructured":"S.M. Glaser, S.F. Mandish, B.S. Gill, G.K. Balasubramani, D.A. Clump et al. Anaplastic thyroid cancer: prognostic factors, patterns of care, and overall survival. Head Neck 38(Suppl 1), E2083\u2013E2090 (2016)","journal-title":"Head Neck"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03008-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03008-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03008-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T11:37:18Z","timestamp":1653997038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03008-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3008"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03008-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"assertion":[{"value":"3 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No competing financial interests exist for all contributory authors. All of the research meets the ethics guidelines, including adherence to the legal requirements of the country where the study was performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}